InVivoMAb anti-human GM-CSF

Pearson C, Thornton EE, McKenzie B, et al. ILC3 GM-CSF production and mobilisation orchestrate acute intestinal inflammation. Elife. 2016,5:e10066. doi: 10.7554/eLife.10066

Kaufmann U, Shaw PJ, Kozhaya L, et al. Selective ORAI1 Inhibition Ameliorates Autoimmune Central Nervous System Inflammation by Suppressing Effector but Not Regulatory T Cell Function. J Immunol. 2016,196(2):573-85. doi: 10.4049/jimmunol.1501406

Li R, Rezk A, Miyazaki Y, et al. Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy. Sci Transl Med. 2015,7(310):310ra166. doi: 10.1126/scitranslmed.aab4176

Rasouli J, Ciric B, Imitola J, et al. Expression of GM-CSF in T Cells Is Increased in Multiple Sclerosis and Suppressed by IFN-β Therapy. J Immunol. 2015,194(11):5085-93. doi: 10.4049/jimmunol.1403243

Kitamura T, Tanaka N, Watanabe J, et al. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor. J Exp Med. 1999,190(6):875-80.